Comprehensive Assessment of Fatty Liver Disease: Merging Clinical, Biochemical, and Radiological Data for Better Outcomes
Saket Gupta , Assistant Professor, Department of Gastroenterology, Himalayan Institute of Medical Sciences, Dehradun, IndiaAbstract
Fatty liver disease (FLD) is a growing global health concern, encompassing a spectrum of liver conditions ranging from simple steatosis to non-alcoholic steatohepatitis (NASH), which can lead to cirrhosis and liver failure. Early diagnosis and effective management of FLD are critical to preventing its progression and improving patient outcomes. This study proposes a comprehensive approach to assessing fatty liver disease by integrating clinical, biochemical, and radiological data. By combining patient history, biochemical markers, and advanced imaging techniques, this multifaceted diagnostic approach provides a more accurate and holistic understanding of the disease, enhancing early detection and personalized treatment strategies. Clinical data, such as risk factors and symptoms, serve as the initial screening tools, while biochemical markers offer insights into liver function and metabolic disturbances. Radiological imaging, including ultrasound, elastography, and MRI, plays a crucial role in assessing liver fat content, fibrosis, and overall liver health. This integrated methodology aims to refine diagnostic accuracy, enable timely intervention, and improve patient outcomes in individuals affected by fatty liver disease.
Keywords
Fatty Liver Disease, Non-Alcoholic Fatty Liver Disease (NAFLD), Non-Alcoholic Steatohepatitis (NASH)
References
Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. APosition statement on NAFLD/NASH based on the EASL 2009special conference. Journal of hepatology.2010 Aug 1;53[2]:372-84.
Sakitani K, Enooku K, Kubo H, Tanaka A, Arai H, Kawazu S, Koike K.Clinical characteristics of patients with diabetes mellitus and fattyliver diagnosed by liver/spleen Hounsfield units on CT scan.Journal of International Medical Research. 2017 Jun;45[3]:1208-20.
Bedogni G, Nobili V, Tiribelli C. Epidemiology of fatty liver: anupdate. World journal of gastroenterology: WJG. 2014 Jul 21;20[27]:9050.
Torres DM, Harrison SA. Nonalcoholic Fatty Liver Disease: ClinicalFeatures, Disease Modifiers, and Natural History. InAlcoholic andNon- Alcoholic Fatty Liver Disease 2016 [pp. 183-194].
Bajaj S, Nigam P, Luthra A, Pandey RM, Kondal D, Bhatt SP, WasirJS, Misra A. A case-control study on insulin resistance, Metabolicco-variates & prediction score in non-alcoholic fatty liver disease.Indian Journal of Medical Research. 2009 Mar 1;129[3]:285.
Amarapurkar D, Kamani P, Patel N, Gupte P, Kumar P, Agal S,Baijal R, Lala S, Chaudhary D, Deshpande A. Prevalence of non-alcoholic fatty liver disease: population based study. Annals of hepatology. 2007;6[3]:161-3.
Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni C1. Prevalence of non-alcoholic fatty liver disease in urban SouthIndians in relation to different grades of glucose intolerance andmetabolic syndrome. Diabetes research and clinical practice.2009 Apr 1;84[1]:84-91.
Singh SP, Nayak S, Swain M, Rout N, Mallik RN, Agrawal O, MeherC, Rao M. Prevalence of nonalcoholic fatty liver disease in coastal eastern India: apreliminary ultrasonographic survey. Tropicalgastroenterology: official journal of the Digestive Diseases Foundation. 2004;25[2]:76-9.
Article Statistics
Downloads
Copyright License
Copyright (c) 2025 Saket Gupta

This work is licensed under a Creative Commons Attribution 4.0 International License.